BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 21685357)

  • 21. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
    Bao Y; Giovannucci EL; Kraft P; Qian ZR; Wu C; Ogino S; Gaziano JM; Stampfer MJ; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Pollak MN; Jiao L; Lessin L; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):855-61. PubMed ID: 23462920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.
    Douglas JB; Silverman DT; Weinstein SJ; Graubard BI; Pollak MN; Tao Y; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):359-69. PubMed ID: 21173171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust.
    Silverman DT; Samanic CM; Lubin JH; Blair AE; Stewart PA; Vermeulen R; Coble JB; Rothman N; Schleiff PL; Travis WD; Ziegler RG; Wacholder S; Attfield MD
    J Natl Cancer Inst; 2012 Jun; 104(11):855-68. PubMed ID: 22393209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum C-reactive protein and risk of lung cancer: a case-control study.
    Xu M; Zhu M; Du Y; Yan B; Wang Q; Wang C; Zhao J
    Med Oncol; 2013 Mar; 30(1):319. PubMed ID: 23254959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C-reactive protein (CRP) in patients with myocardial infarction].
    Marciniak A; Gierbliński I; Stefański R; Łapiński M; Gaciong Z; Bartłomiejczyk I; Zegarska J
    Pol Arch Med Wewn; 2003 Jan; 109(1):15-22. PubMed ID: 12879762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis.
    Heikkilä K; Harris R; Lowe G; Rumley A; Yarnell J; Gallacher J; Ben-Shlomo Y; Ebrahim S; Lawlor DA
    Cancer Causes Control; 2009 Feb; 20(1):15-26. PubMed ID: 18704713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
    Pinsky PF; Kramer BS
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
    J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonates with reduced neonatal lung function have systemic low-grade inflammation.
    Chawes BL; Stokholm J; Bønnelykke K; Brix S; Bisgaard H
    J Allergy Clin Immunol; 2015 Jun; 135(6):1450-6.e1. PubMed ID: 25579483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
    Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial.
    Brown D; Zingone A; Yu Y; Zhu B; Candia J; Cao L; Ryan BM
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):110-118. PubMed ID: 30297515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
    Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
    JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein, interleukin-6 and pre-eclampsia: large-scale evidence from the GenPE case-control study.
    Serrano NC; Guio E; Becerra-Bayona SM; Quintero-Lesmes DC; Bautista-Niño PK; Colmenares-Mejía C; Páez MC; Luna ML; Díaz LA; Ortiz R; Beltrán M; Monterrosa Á; Miranda Y; Mesa CM; Saldarriaga W; Casas JP
    Scand J Clin Lab Invest; 2020 Sep; 80(5):381-387. PubMed ID: 32400228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM; George S; Rosner B; Rifai N
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study.
    Van't Klooster CC; Ridker PM; Hjortnaes J; van der Graaf Y; Asselbergs FW; Westerink J; Aerts JGJV; Visseren FLJ
    Eur Heart J; 2019 Dec; 40(48):3901-3909. PubMed ID: 31504409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
    Sollie S; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Santaolalla A; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
    BMC Cancer; 2019 Aug; 19(1):858. PubMed ID: 31464604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.